ACB

Aurora Cannabis Inc. Common Shares (ACB)

Stock · NASDAQ · Health Care

$4as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

Aurora Faces Turbulence as Curaleaf Pursues Hostile Takeover. Curaleaf has launched a hostile bid for Aurora Cannabis, sparking a battle over shareholder rights. In response, Aurora filed a request with the Alberta Securities Commission to protect shareholders and highlighted deficiencies in Curaleaf's disclosure. The move has drawn mixed attention, with Aurora being named a Zacks Bull of the Day while also appearing on a Bear list, and the sector roundup notes continued volatility.

Active signals

Support level
$3.38
Industry
Medicinal Chemicals and Botanical Products

What ACB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike30-8.6%37%
Bollinger Band Breakout26-13.0%23%
Bollinger Band Breakdown18-0.1%50%
200-Day Moving Average TouchActive now8+1.5%50%
Any 20-session window (baseline)-3.6%39%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About ACB

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannab…

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Employees
1,028

Fundamentals

1-day range
$3.98$4.12
Market cap
$184.63M
P/E (trailing)
—
P/E (forward)
-36.27
EPS (trailing)
$-1.94
Dividend yield
—
Beta
1.72
Avg. volume
1.35M
Dividend pay date
May 11, 2020
52-week range
$3.59$8.75
Next earnings: November 4, 2026 · EPS estimate $-0.09confirmed

Aurora Cannabis Inc. Common Shares Competitors

Chosen by industry and closest market cap.

  • ACB
    Aurora Cannabis Inc. Common Shares
    $3.99
    ▼ 2.68%
    Market cap $184.63MP/E —
    $3.59$8.75
  • MDWD
    MediWound Ltd. Ordinary Shares
    $11.85
    ▼ 2.95%
    Market cap $183.44MP/E —
    $11.9$20.03
  • NAGE
    Niagen Bioscience Inc. Common Stock
    $2.49
    ▼ 3.49%
    Market cap $240.54MP/E 12.74
    $2.51$7.95
  • OBIO
    Orchestra BioMed Holdings Inc. Ordinary Shares
    $5.45
    ▼ 5.05%
    Market cap $248.50MP/E —
    $3.1$6.5
  • FTLF
    FitLife Brands Inc. Common Stock
    $8.39
    ▼ 2.21%
    Market cap $95.88MP/E 12.92
    $8.5$20.15
  • ISPR
    Ispire Technology Inc. Common Stock
    $1.35
    ▼ 6.25%
    Market cap $95.28MP/E —
    $1.01$3.87
  • USNA
    USANA Health Sciences Inc. Common Stock
    $15.54
    ▲ 1.04%
    Market cap $274.91MP/E 32.28
    $12.57$23.59

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.